Figure S10 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602170

2024-01-01

Abstract:Figure S10. The representative flow plots of Figure S10A-B are shown in Figure 4C-D.

What problem does this paper attempt to address?

Figure S17 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602143

2024-01-01

Abstract:Figure S17. The representative flow plots related to Figure 7G.
Figure S14 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602152

2024-01-01

Abstract:Figure S14. Postoperative recurrence and brain metastasis rates.
Figure S15 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602149

2024-01-01

Abstract:Figure S15. Figure 6B shows the individual tumor growth curves of PDX tumor-bearing mice subjected to different treatments.
Figure S12 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602161

2024-01-01

Abstract:Figure S12. Individual tumor growth curves of parental MDA-MB-231 tumor-bearing mice subjected to different treatments (related to Figure 5B).
Figure S9 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602113

2024-01-01

Abstract:Figure S9. Flow cytometric analysis of the impact of CAT and/or hydrogel on the phenotype of related CAR-NK cells labeled with anti-CD3-PE-Cy7 or anti-CD56-PE.
Figure S8 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602119

2024-01-01

Abstract:Figure S8. The proliferation rates of HER1-CAR-CAT-NK cells incubated with or without the ALG hydrogel were determined by counting the number of cells.
Figure S1 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602173

2024-01-01

Abstract:Figure S1. H2O2 contents in the blood and tumor interstitial fluid of parental MDA-MB-231 tumors (A), brain metastatic MDA-MB-231 tumors (B), and MDA-MB-468 tumors (C). (***p < 0.001).
Figure S2 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602140

2024-01-01

Abstract:Figure S2. HER1 expression levels in 293T cells, parental MDA-MB-231 cells, and brain metastatic MDA-MB-231 cells via real-time PCR (A), western blotting (B) and flow cytometry (C). (***p < 0.001).
Figure S13 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602158

2024-01-01

Abstract:Figure S13. Individual tumor growth curves of brain metastatic MDA-MB-231 tumor-bearing mice subjected to different treatments (related to Figure 5F).
Figure S3 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602137

2024-01-01

Abstract:Figure S3. The percentages of live parental MDA-MB-231 cells (A) and brain metastatic MDA-MB-231 cells (B) incubated with different concentrations of H2O2 for 24 h determined via propidium iodide staining.
Figure S4 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602134

2024-01-01

Abstract:Figure S4. The percentages of live parental MDA-MB-231 cells (A) and brain metastatic MDA-MB-231 cells (B) incubated under normoxic or hypoxic conditions for 24 h were determined via propidium iodide staining.
Figure S7 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602122

2024-01-01

Abstract:Figure S7. Photographs of ALG hydrogels cultured with PBS and H2O2 as indicated.
Figure S16 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602146

2024-01-01

Abstract:Figure S16. Individual tumor growth curves of primary untreated (A) and distant untreated (B) TNBC PDX tumor-bearing mice subjected to different treatments (related to Fig. 7B and C, respectively).
Figure S11 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602167

2024-01-01

Abstract:Figure S11. Semiquantitative statistical analysis of percentages of specific areas affected by pimonidazole based on the fluorescence images in Figure 4I. (***p < 0.001, **p < 0.01).
Figure S5 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602131

2024-01-01

Abstract:Figure S5. Effects of H2O2 and hypoxia exposure on the migration and invasion abilities of parental and brain metastatic MDA-MB-231 cells. (A-B) Optical microscopic observation and corresponding semiquantitative analysis of the migration rates of parental MDA-MB-231 cells (A) and brain metastatic MDA-MB-231 cells (B) treated with different concentrations of H2O2 under normoxic or hypoxic conditions for 24 h. (C-D) Optical microscopic observation and corresponding semiquantitative analysis of the invasion rates of parental MDA-MB-231 cells (C) and brain metastatic MDA-MB-231 cells (D) treated with different concentrations of H2O2 under normoxic or hypoxic conditions for 24 h.
Figure S6 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602125

2024-01-01

Abstract:Figure S6. HER1-CAR-CAR-NK cells inhibit the migration and invasion of TNBC cells under H2O2-enriched and hypoxic conditions. (A) Scheme of the setup for the transwell migration assay. (B-C) Optical microscopic observation (B) and corresponding semiquantitative analysis (C) of the migration rate of parental and brain metastatic MDA-MB-231 cells after coincubation with different CAR-NK cells under different conditions, as indicated by the color code. (D) Scheme of the experimental schedule for the transwell invasion assay. (E-F) Optical microscopic examination (E) and corresponding semiquantitative analysis (F) of the invasion rate of parental and brain metastatic MDA-MB-231 cells after coincubation with different CAR-NK cells under different conditions, as indicated by the color code. (*p < 0.05).
Supplementary Table S1 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602110

2024-01-01

Abstract:Primer sequences for real-time PCR
Engineered CAR-NK cells with tolerance to H2O2 and hypoxia can suppress postoperative relapse of triple-negative breast cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.cir-23-1017

IF: 10.1

2024-07-19

Cancer Immunology Research

Abstract:Surgical resection is a primary treatment option for triple-negative breast cancer (TNBC) patients, but it is associated with a high rate of postoperative local and metastatic relapse. Although chimeric antigen receptor–engineered natural killer (CAR-NK) cell therapy can specifically recognize and eradicate tumor cells, its therapeutic potency toward TNBCs is markedly suppressed by the hostile tumor microenvironment, which restricts the infiltration, survival and effector functions of CAR-NK cells inside the tumor masses. Herein, HER1-overexpressing TNBC-targeted CAR-NK (HER1-CAR-NK) cells were genetically engineered with catalase to endow them with tolerance toward the high levels of oxidative stress and hypoxia inside TNBC tumors through the catalytic decomposition of hydrogen peroxide, which is a principle reactive oxygen species inside tumors, into O2. We refer to these cells as HER1-CAR-CAT-NK cells. Upon intratumoral fixation with an injectable alginate hydrogel, HER1-CAR-CAT-NK cells enabled sustained tumor hypoxia attenuation and exhibited markedly enhanced persistence and effector functions inside TNBC tumors. As a result, locoregional HER1-CAR-CAT-NK cell therapy not only inhibited the growth of local primary residual tumors, but also elicited systemic antitumor activity to suppress the growth of distant tumors. This study highlights that genetic engineering of HER1-CAR-NK cells with catalase is a promising strategy to suppress the postoperative local and distant relapse of TNBC tumors.

oncology,immunology
Figure S6 from Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>in Vitro</i> and Patient-Derived Xenografts <i>in Vivo</i>

Maoyong Song,Xuejiao Liu,Kangdong Liu,Ran Zhao,Hai Huang,Yuanyuan Shi,Man Zhang,Silei Zhou,Haiyang Xie,Hanyong Chen,Yin Li,Yufeng Zheng,Qiong Wu,Fangfang Liu,En‐Min Li,Ann M. Bode,Zigang Dong,Mee-Hyun Lee

DOI: https://doi.org/10.1158/1535-7163.22506771.v1

2023-01-01

Abstract:Oridonin attenuates the growth of PDX tumors in mice. (A) The effect of oridonin on the volume of PDX tumors (EG9) was plotted over 40 days. Vehicle or oridonin (40 or 160 mg/kg) was administered by gavage. Tumor volume was measured twice a week. The asterisk (* p < 0.05) indicates a significant decrease in volume of tumors from oridonin-treated mice compared to vehicle-treated mice. Data are shown as mean values {plus minus} S.E. (B) Body weight of mice (EG9) was plotted over 40 days. (C) The photographs show tumors from PDX mice treated with vehicle or oridonin (40 mg/kg or 160 mg/kg). (D) The expression of Ki-67, pAKT, pGSK-3β or p-mTOR was examined by IHC analysis (100X magnification; upper panel). The expression of Ki-67, pAKT, pGSK-3β or p-mTOR was quantified from 4 separate areas on each slide and an average of 5 (vehicle) or 6 (oridonin-treated) samples per group (lower panel). Data are expressed as IOD values {plus minus} S.D. The asterisks (* p < 0.05, ** p < 0.01) indicate a significant decrease in Ki-67, pAKT (Ser473), pGSK-3β (Ser9) or p-mTOR (Ser2448) in treated tissues compared to untreated controls. (E) Characteristic information of patients (EG9 and HEG18) whose tumors were used in the PDX mouse model. (F) H&E staining (left panel) and weights of spleen and liver (right panel) in EG9 and HEG18 tissues.
Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Zhen–Bin Ding,Bo Hui,Ying‐Hong Shi,Jing Zhou,Yuan‐Fei Peng,Chengyu Gu,Hua Ye,Guo‐Ming Shi,Ai‐Wu Ke,Xiaoying Wang,Kun Song,Zhi Dai,Yongchun Shen,Jia Fan

DOI: https://doi.org/10.1158/1078-0432.22443171.v1

2023-01-01

Abstract:PDF file - 594K, Analysis of transfection efficiency by fluorescent microscopy.

Figure S10 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S17 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S14 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S15 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S12 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S9 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S8 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S1 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S2 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S13 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S3 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S4 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S7 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S16 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S11 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S5 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Figure S6 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Supplementary Table S1 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Engineered CAR-NK cells with tolerance to H2O2 and hypoxia can suppress postoperative relapse of triple-negative breast cancers

Figure S6 from Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma &lt;i&gt;in Vitro&lt;/i&gt; and Patient-Derived Xenografts &lt;i&gt;in Vivo&lt;/i&gt;

Supplementary Figure 1 from Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin Via Reactive Oxygen Species Modulation

Figure S6 from Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>in Vitro</i> and Patient-Derived Xenografts <i>in Vivo</i>